Bartlett & Co. LLC increased its position in Colgate-Palmolive (NYSE: CL – Get Rating) by 0.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 120,612 shares of the company stock after buying an additional 166 shares during the period. Bartlett & Co. LLC’s holdings in Colgate-Palmolive were worth $ 10,293,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of the stock. BlackRock Inc. grew its position in Colgate-Palmolive by 8.4% in the fourth quarter. BlackRock Inc. now owns 65,218,485 shares of the company stock worth $ 5,565,745,000 after acquiring an additional 5,039,853 shares in the last quarter. State Street Corp increased its position in Colgate-Palmolive by 1.6% during the fourth quarter. State Street Corp now owns 49,282,107 shares of the company stock worth $ 4,205,735,000 after buying an additional 753,469 shares during the last quarter. Geode Capital Management LLC raised its holdings in Colgate-Palmolive by 4.8% during the fourth quarter. Geode Capital Management LLC now owns 15,342,882 shares of the company stock valued at $ 1,306,535,000 after buying an additional 707,482 shares in the last quarter. Deutsche Bank AG lifted its position in shares of Colgate-Palmolive by 4.0% in the fourth quarter. Deutsche Bank AG now owns 8,093,507 shares of the company stock worth $ 690,698,000 after buying an additional 311,952 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Colgate-Palmolive by 2.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 7,362,817 shares of the company stock worth $ 628,344,000 after acquiring an additional 209,017 shares in the last quarter. 78.12% of the stock is currently owned by hedge funds and other institutional investors.
A number of brokerages have issued reports on CL. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $ 90.00 to $ 88.00 in a research report on Wednesday, April 13th. TheStreet upgraded shares of Colgate-Palmolive from a “c +” rating to a “b” rating in a research note on Friday, April 29th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, April 13th. Raymond James started coverage on Colgate-Palmolive in a research report on Thursday, April 7th. They issued a “market perform” rating on the stock. Finally, The Goldman Sachs Group cut their price target on Colgate-Palmolive from $ 104.00 to $ 95.00 in a research report on Tuesday, March 29th. One investment analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $ 85.40.
Shares of CL opened at $ 74.04 on Friday. The company has a quick ratio of 0.67, a current ratio of 1.09 and a debt-to-equity ratio of 10.42. The company has a 50-day moving average price of $ 78.11 and a two-hundred day moving average price of $ 79.09. The stock has a market cap of $ 62.04 billion, a price-to-earnings ratio of 30.60, a P / E / G ratio of 4.99 and a beta of 0.56. Colgate-Palmolive has a 12 month low of $ 72.20 and a 12 month high of $ 85.61.
Colgate-Palmolive (NYSE: CL – Get Rating) last announced its quarterly earnings results on Friday, April 29th. The company reported $ 0.74 EPS for the quarter, meeting the consensus estimate of $ 0.74. Colgate-Palmolive had a return on equity of 296.77% and a net margin of 11.70%. The business had revenue of $ 4.40 billion for the quarter, compared to analyst estimates of $ 4.40 billion. During the same quarter in the previous year, the firm earned $ 0.80 EPS. Colgate-Palmolive’s quarterly revenue was up 1.3% on a year-over-year basis. Equities research analysts expect that Colgate-Palmolive will post 3.05 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, August 15th. Investors of record on Thursday, July 21st will be given a dividend of $ 0.47 per share. This represents a $ 1.88 dividend on an annualized basis and a dividend yield of 2.54%. The ex-dividend date of this dividend is Wednesday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 77.69%.
Colgate-Palmolive announced that its Board of Directors has approved a share repurchase plan on Thursday, March 10th that authorizes the company to repurchase $ 5.00 billion in shares. This repurchase authorization authorizes the company to purchase up to 8.1% of its shares through open market purchases. Shares repurchase plans are often an indication that the company board of directors believes its stock is undervalued.
In other Colgate-Palmolive news, VP Philip G. Shotts sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $ 78.52, for a total value of $ 785,200.00. Following the transaction, the vice president now directly owns 46,094 shares of the company stock, valued at $ 3,619,300.88. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction on Monday, June 6th. The stock was sold at an average price of $ 79.34, for a total value of $ 3,967,000.00. Following the completion of the transaction, the chief executive officer now owns 221,790 shares in the company, valued at $ 17,596,818.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 79,683 shares of company stock worth $ 6,297,119. Company insiders own 0.32% of the company stock.
Colgate-Palmolive Company Profile: (Get Rating)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Receive News & Ratings for Colgate-Palmolive Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.